[Federal Register Volume 78, Number 78 (Tuesday, April 23, 2013)]
[Notices]
[Page 23958]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-09535]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; 
Wildlife Laboratories, Inc.

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 7, 2013, Wildlife 
Laboratories Inc., 1230 W. Ash Street, Suite D, Windsor, Colorado 
80550, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of 
Carfentanil (9743), a basic class of controlled substance listed in 
schedule II.
    The company plans to manufacture the above listed controlled 
substance for sale to veterinary pharmacies, zoos, and for other animal 
and wildlife applications.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substance, may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than June 24, 2013.

    Dated: April 16, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-09535 Filed 4-22-13; 8:45 am]
BILLING CODE 4410-09-P